‘Emerging research priorities within pre-hospital care’ with Sarah McLaughlin and Lisa Ramage.

In this interview we will examine the emerging research priorities within pre-hospital care from the perspective of priority and importance. I will be speaking with Sarah McLaughlin – a senior research fellow with affiliations with Essex & Herts Air Ambulance (EHAAT) and Anglia Ruskin University. I will also be speaking with Lisa Ramage, Lisa is a PHEM trainee in the East of England and the chair of PHOTON. PHOTON is a group of non-consultant grade, pre-hospital, doctors with an ambition to expand the quality and reach of research within pre-hospital care. In this conversation we are going to examine a national Delphi study which is defining the national research priorities within pre-hospital care in the contemporary climate. We will also: Examine what is a Delphi study Why is it an important time for empirical research and audit at the moment within pre-hospital care Sarah’s EHAAT Delphi study as an analogue of the national PHOTON study The process of a Delphi study in terms of rounds and refinement of the questions. How does it achieve consensus? What are the advantages to a Delphi study? Ethical approval (the panel and process) Topics that have emerged from the process Why is it important to study end points that don’t always involve mortality (look at 30 day outcome, CPC neurological outcome, discharge data, and patient centred outcomes) How does this inform national strategic direction and focus Final thoughts from Sarah and Lisa & take-home messages. You can find out more about PHOTON and Lisa Ramage here: https://fphc.rcsed.ac.uk/about/photon-group You can find out more about EHAAT here: https://www.ehaat.org/about-us/our-people/ You can find the EHAAT Delphi study that is mentioned in the interview here: https://sjtrem.biomedcentral.com/articles/10.1186/s13049-021-00835-z You can find some of Sarah McLaughlin's publications here: https://www.researchgate.net/profile/Sarah-Mclachlan-5 This podcast is brought to you in association with BHA Medical. BHA medical source, supply and implement innovative medical technology and solutions across the globe. BHA provide market leading services in covid 19 testing kits, medical products, smart technology and consultancy. One of the latest solutions that BHA medical offer is the iMed end-to-end Covid-19 testing and monitoring solution. NPH iMed is an end-to-end Covid-19 testing and monitoring solution, developed in partnership with BHA Medical Limited to assist in collating and managing test results, reopen travel, leisure, events and entertainment. One of the first independent online test verification systems in the world, NPH iMed is a leading solution for testing, managing and monitoring all of your Covid-19 needs. NPH Group has simplified the process of reporting test result data for you through our online platform which makes capturing the required data for submission easy, while easily recalling individuals for repeat testing and submissions. NPH have created a fully compliant and automatic upload capability, so you don’t have to worry about it, with a cost-effective solution. More can be found here: https://bha-medical.com https://www.bha-medical.com/imed-self-testing-monitoring-covid-19-app Please enjoy this episode with two insightful and engaging guests